Financial statements Lock Pharma
Balance sheet data of LOCK PHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 2 229 829,20 | 2 133 559,64 | 2 034 325,83 | 2 310 649,73 | 2 133 723,55 | 2 473 662,34 |
| A. Fixed assets | 132 425,92 | 139 117,19 | 134 848,76 | 132 726,81 | 554 679,26 | 552 557,31 |
| B. Current assets | 2 097 403,28 | 1 994 442,45 | 1 899 477,07 | 2 177 922,92 | 1 579 044,29 | 1 921 105,03 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 2 229 829,20 | 2 133 559,64 | 2 034 325,83 | 2 310 649,73 | 2 133 723,55 | 2 473 662,34 |
| A. Equity | 1 503 972,15 | 1 473 411,42 | 1 340 263,87 | 1 495 438,26 | 1 555 012,04 | 1 624 457,89 |
| B. Liabilities and provisions for liabilities | 725 857,05 | 660 148,22 | 694 061,96 | 815 211,47 | 578 711,51 | 849 204,45 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 725 857,05 | 660 148,22 | 694 061,96 | 815 211,47 | 578 711,51 | 849 204,45 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.